ICU Medical, Inc. (NASDAQ:ICUI) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of ICU Medical, Inc. (NASDAQ:ICUI) have received an average recommendation of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $179.3333.

A number of equities research analysts recently commented on the company. KeyCorp increased their price target on ICU Medical from $175.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday, February 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Sunday, February 15th. Finally, Piper Sandler increased their target price on ICU Medical from $172.00 to $178.00 and gave the stock an “overweight” rating in a report on Friday, February 20th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ICUI. Maryland State Retirement & Pension System increased its position in ICU Medical by 2.0% in the 4th quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock valued at $516,000 after acquiring an additional 70 shares in the last quarter. Arizona State Retirement System lifted its position in shares of ICU Medical by 1.3% during the third quarter. Arizona State Retirement System now owns 6,903 shares of the medical instruments supplier’s stock worth $828,000 after purchasing an additional 91 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of ICU Medical by 1.8% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 100 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in shares of ICU Medical by 11.6% during the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock valued at $128,000 after purchasing an additional 101 shares during the last quarter. Finally, Lido Advisors LLC increased its holdings in shares of ICU Medical by 4.5% in the fourth quarter. Lido Advisors LLC now owns 2,479 shares of the medical instruments supplier’s stock valued at $354,000 after purchasing an additional 106 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Trading Down 3.5%

Shares of ICU Medical stock opened at $132.00 on Tuesday. ICU Medical has a 12-month low of $107.00 and a 12-month high of $160.29. The stock has a market capitalization of $3.26 billion, a P/E ratio of 6,603.30, a price-to-earnings-growth ratio of 1.90 and a beta of 0.79. The company has a 50-day simple moving average of $149.21 and a 200 day simple moving average of $137.88. The company has a quick ratio of 1.15, a current ratio of 2.39 and a debt-to-equity ratio of 0.60.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 EPS for the quarter, beating analysts’ consensus estimates of $1.68 by $0.23. The firm had revenue of $535.94 million for the quarter, compared to analyst estimates of $541.20 million. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. The company’s revenue for the quarter was down 14.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.11 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Research analysts expect that ICU Medical will post 4.11 earnings per share for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.